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SUMMARY – Morbid obesity is currently one of the leading problems worldwide. More than 
1 of 5 adults in Croatia are considered obese, with a body mass index (BMI) higher than 30 kg/
m², with no sex differences. Indications for bariatric surgery are BMI >40 kg/m² or BMI >35 kg/m² 
with comorbidities. Bariatric procedures are divided into restrictive, malabsorptive, and combined 
procedures. The Roux-en-Y gastric bypass is a combined bariatric procedure, already being accepted 
as the standard one in the USA and gaining ground in Europe as well. A 47-year-old woman with 
BMI of 48.2 kg/m² (105.5 kg) was hospitalized at our department. Her increasing attempts to lose 
weight using conservative methods showed no success. She also suffered from glucose intolerance, 
gastritis, chronic obstructive pulmonary disease, hypertension and depression as comorbidities. Ba-
sed on our experience in bariatric surgery (gastric banding, sleeve gastrectomy, duodenal switch), 
we decided for the first time in our hospital to perform laparoscopic Roux-en-Y gastric bypass. The 
patient was released on the fifth postoperative day with BMI of 40.56 kg/m² (100 kg body weight), 
excess weight loss 12.5%. One month after the procedure, her BMI was 38.54 kg/m², excess weight 
loss 23.92% (body weight 95 kg).
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Introduction
Morbid obesity is nowadays one of the leading 
health problems worldwide. At least 1.1 billion adults 
are overweight and 312 million of them are consid-
ered obese. In Europe, the prevalence of obesity (body 
mass index, BMI >30 kg/m2) is within the range of 
10%-20% in men and 15%-25% in women1. In Croa-
tia, the prevalence of obesity (data from 2003) is more 
than 20%, with no sex differences2.
Overweight and obesity are associated with an in-
creased risk of type 2 diabetes, hypertension, cardio-
vascular disease, dyslipidemia, arthritis, nonalcoholic 
steatohepatitis, gallbladder disease, sleep apnea syn-
drome, and several types of cancer1.
Surgical treatment of morbid obesity is indicated in 
patients with a BMI >40 kg/m2 and BMI >35 kg/m2 
accompanied by comorbidities3. Surgical procedures 
in bariatric surgery are restrictive, malabsorptive and 
combined restrictive-malabsortive1 (Table 1).
One of the most popular procedures in the USA 
is the laparoscopic Roux-en-Y gastric bypass (LRYG-
BP). The aim of this report is to present our first 
LRYGBP, based on the experience in other bariatric 
surgery procedures4-9.
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Case Report
The subject was a 47-year-old woman with BMI 
of 42.8 kg/m2 (body weight 105.5 kg) accompanied 
with the following comorbidities: glucose intolerance, 
gastritis, chronic obstructive pulmonary disease, hy-
pertension and depression. Her increasing attempts 
to reduce body weight using conservative treatment 
showed no success. Prior to the operation she was 
examined by an endocrinologist and a psychologist 
(members of our bariatric surgery team). Her blood 
tests, liver function tests, renal function tests, chest x-
ray and spirometry tests were performed accordingly.
After thorough evaluation we decided to perform 
the LRYGBP. The procedure started after the patient 
had been introduced into general anesthesia and en-
dotracheal intubation. The laparoscopic tower was 
placed on the right side of the patient, the surgeon 
standing between the legs of the patient and the assis-
tants being on her right and left side. The first trocar 
(10 mm) for optical instrument was placed on the left 
from the medial line, 20 cm below the xyphoid. The 
other two 12-mm trocars were positioned on the left 
and right side in the upper abdominal quadrants in 
the middle clavicular line and two 5-mm trocars on 
the left side to enable liver retraction and on the right 
for extra assistance (Fig. 1).
We started with dissection of the less curvature 
at the level of the third vascular arcade and created a 
window to the posterior stomach (Fig. 2), after dis-
secting the Hiss angle and left crura (Fig. 3). After 
this, the stomach was transsected at that level by one 
horizontal firing of the linear stapler (45 mm, blue 
cartridge) and with 3 vertical firings (45 mm, blue 
cartridge). The omentum was dissected with the ul-
trasonic scalpel, then the angle of Treitz was identi-
fied, the jejunum was mobilized 50 cm from Treitz, 
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linear stapler (blue cartridge) (Fig. 4). Both openings 
for linear stapler (on the stomach and jejunum) were 
closed with running 2-0 slow resorptive suture.
Finally, we measured 150 cm of the alimentary 
loop and prepared enteroenterostomy with 45-mm 
linear stapler (white cartridge) (Fig. 5). Both open-
ings on the jejunum were closed with running 2-0 
slow resorptive suture. Then we checked anastomosis 
with the introduction of a nasogastric tube, immersed 
operating field in the saline solution and insufflated 
air through the nasogastric tube. Anastomosis was 
checked with methylene blue. The penrose drain was 
placed in the vicinity of both anastomotic sites.  
Sugar free liquid diet was started on the 2nd postop-
erative day, after the peristalsis had been established. 
The patient was allowed to leave the hospital on the 5th 
postoperative day. The patient was recommended to 
undergo conservative therapy: proton pump inhibitor 
substitution of iron, vitamin B12 and minerals.
Results
The operative procedure lasted for 170 minutes, 
and the immediate and late postoperative period 
showed no complications10,11. On one-month follow 
up, the patient’s body weight was 95 kg, BMI 38.54 
and excess weight loss (EWL) 23.92%12. In the next 
period (3 and 6 months of the surgery) we expected 
the comorbidities to disappear13-15, and the BMI and 
EWL to keep decreasing (about 33% in 3 months and 
55% in 6 months)12,13,16. In the first 12 months, EWL 
should be about 60%13,15-17. 
In the following period, the patient’s nutritional 
and metabolic status is to be monitored, including 
HbA1c in diabetics, liver function tests, renal function, 
vitamin B12, D3, ferritin, calcium, parathyroid hor-
mone, albumin, HB, magnesium, zinc, and on the ba-
sis of these tests compensate the deficits by prescribing 
vitamins and micronutrients1,18,19.
Discussion
LRYGBP is the most commonly performed bar-
iatric procedure in the USA, and the second in Eu-
rope, next to adjustable gastric banding (GB)3. The 
LRYGBP belongs to combined restrictive-malabsorp-
tive procedures with many advantages over GB. The 
expected EWL after LRYGBP is higher than after 
GB procedure (70% LRYGBP vs. 50% GB). Also, the 
regression of comorbidities is better after LRYGBP 
than after GB procedure (70% regression of DM after 
LRYGBP vs. 50% regression after GB)14. Periopera-
tive complications are more frequent after LRYGBP 
than after GB (9% vs. 5%) because LRYGBP is tech-
nically more demanding than GB13. The length of 
Roux limb can be 80-150 cm (long limb)15,20. EWL is 
faster in patients with long Roux limb but it is similar 
Fig. 4.
Fig. 5.
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in both limbs in the first 48 months. Patients with 
long Roux limb have better diabetes type 2 control 
and lipid disorder improvement15. After LRYGBP, 
patients are expected to stick to the lifelong nutrition-
al and metabolic assessment with an adequate reim-
bursement of deficits. 
Some investigations showed the increasing con-
centration of apolipoprotein A-IV. Apo A-IV is 
produced in bypassed intestine and in the liver after 
LRYGBP21. Apo A-IV inhibits gastric emptying and 
produces the feeling of satiety, but Apo A-IV also has 
anti-inflammatory and antiatherogenic effects and in-
fluences the improvement of cardiovascular diseases 
after LRYGBP21.
The early and late mortality after bariatric surgery 
is low. Mortality risk depends on the type of surgi-
cal procedure, open surgery, operative time, comor-
bidities, and volume of activity22. The most common 
cause of death is pulmonary embolism. Other causes 
of mortality are cardiac failure, intestinal leak, respi-
ratory failure, marginal ulcer, cerebral and intestinal 
ischemia, and internal hernia22-24.
One of the most serious complications after LRYG-
BP are anastomotic leaks25. Most of them occurred at 
the gastrojejunostomy, then at excluded stomach, je-
juno-jejunostomy, gastric pouch, and uncertain loca-
tion. Anastomotic leaks can be treated conservatively 
or operatively10,26,27. In 3%-25% of cases, anastomotic 
strictures occur at gastrojejunal anastomosis. It can 
also be treated conservatively (balloon dilatation) or 
surgically27. A potentially serious complication after 
LRYGBP is marginal ulcer, and it should be treated 
conservatively or surgically28.
Conclusion
LRYGBP is an effective and rather 
safe bariatric procedure. It provides an ef-
fective EWL and BMI decrease, as well 
as control and regression of comorbidities 
in morbidly obese patients. Only experi-
enced surgeons in advanced laparoscopic 
and bariatric surgeries should perform 
this procedure. Because of many advan-
tages of LRYGBP over GB, we should 
prefer this procedure at our department, 
and plan to increase the number of these 
bariatric procedures in the future.
References
  1. JAMES WPT, RIGBY N, LEACH R. The obesity epidem-
ic, metabolic syndrome and future prevention strategies. Eur 
J Cardiovasc Prev Rehab 2004;11:3-8.
  2. HEIM I, LEONTIć K, GOSTOVIć MJ. Obesity and 
overweight in Croatia. Acta Med Croat 2007;61:267-73.
  3. MILLER K. Obesity: surgical options. Best Pract Res Clin 
Gastroenterol 2004;18:1147-65. 
  4. FRANJIć BD, PULJIZ Z, GRGIć T, et al. Laparoscopic 
surgery in the treatment of morbid obesity: first experiences 
with the Swedish adjustable gastric band at Sestre milosrd-
nice University Hospital. Acta Chir Croat 2004;1:9-13. (in 
Croatian)
  5. BEKAVAC-BEšLIN M. Učenje, uvođenje metode, uspjesi 
i komplikacije LAP “bandinga”. 2nd Croatian Congress on 
Obesity with International Participation, Opatija, April 7-9, 
2006; p. 94. (in Croatian)
  6. KULIš T, GLAVAN E, šKORJANEC S, et al. Biliopancre-
atic diversion with sleeve    gastrectomy and antroileal anasto-
mosis – case report. Acta Clin Croat 2007;46:37-40.
  7. GRGIć T, KULIš T, VIDOVIć D, et al. Laparoscopic 
sleeve gastrectomy for morbid obesity – case report. Acta 
Chir Croat 2008;5:20-2.
  8. BEKAVAC-BEšLIN M, FRANJIć BD, ZJAčIć-
ROTKVIć V, et al. Bariatric surgery in Croatia. 11th World 
Congress of the International Federation for Surgery of Obe-
sity, 20th International Symposium on Obesity Surgery, Syd-
ney, Australia, August 30 – September 2, 2006; p. 123.
  9. NOVINšćAK T, DOLOVSKI Z, MATKOVIć K, et al. 
Rani rezultati nove operacijske tehnike u liječenju morbidne 
pretilosti. 6th Congress of the Croatian Society of Digestive 
Surgery, Opatija, May 18-21, 2005; p. 94. (in Croatian)
10. THODIYIL PA, YENUMULA P, ROGULA T, et al. Se-
lective nonoperative management of leaks after gastric by-
Restrictive 
procedures
– Adjustable gastric banding




– Biliopancreatic diversion and duodenal switch
– Long limb Roux-en-Y gastric bypass   
Combined 
procedures
– Roux-en-Y gastric bypass
– Sleeve gastrectomy with duodenal switch
– Sleeve gastrectomy with biliopancreatic diversion 
and antroileal anastomosis
Table 1. Bariatric procedures
Acta Clin Croat,  Vol. 50,  No. 2,  2011 243
T. Grgić et al. Laparoscopic Roux-en-Y gastric bypass for morbid obesity – case report
pass: lessons learned from 2675 consecutive patients. Ann 
Surg 2008;248:782-92.
11. AUGUSTE T, Le ROUX Y, BREFORT JL, et al. Omental 
infarct after a gastric bypass. J Chir (Paris) 2008;145:390-1. 
(in French)
12. DENG JY, LOURIE DJ. 100 robotic assisted laparo-
scopic gastric bypass at a community hospital. Am Surg 
2008;74:1022-5.
13. TICE JA, KARLINER L, WALSH J, et al. Gastric band-
ing or bypass? A systematic review comparing the two most 
popular bariatric procedures. Am J Med 2008;121:885-93.
14. NGUYEN NT, VARELA E, SABIO A, et al. Resolution of 
hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J 
Am Coll Surg 2006;203:24-9.
15. PINHERO JS, SCHIAVON CA, PEREIRA PB, et al. 
Long-limb Roux-en-Y gastric bypass is more efficacious in 
the treatment of type 2 diabetes and lipid disorders in super-
obese patients. Surg Obes Relat Dis 2008;4:521-5; discussion 
526-7. 
16. KHALAILEH A, MATOT I, SCHWEIGER C, et al. 
Laparoscopic Roux-en-Y gastric bypass for the treatment of 
morbid obesity: experience with 50 patients. Isr Med Assoc J 
2008;10:350-3.
17. BAVARESCO M, PAGANINI S, LIMA TP, et al. Nutri-
tional course of patients submitted to bariatric surgery. Obes 
Surg 2010;20:716-21.
18. CLEMENTS RH, YELLUMAHANTHI K, WESLEY 
M, et al. Hyperparathyroidism and vitamin D deficiency 
after laparoscopic gastric bypass. Am Surg 2008;74:469-74; 
discussion 474-5.
19. MAHLAY NF, VERKA LG, THOMSEN K, et al. Vitamin 
D status before Roux-en-Y and efficacy of  prophylactic and 
therapeutic doses of vitamin D in patients after Roux-en-Y 
gastric bypass surgery. Obes Surg 2009;19:590-4.
20. LANCASTER LT, HUTTER MM. Bands and bypasses: 
30-day morbidity and mortality of bariatric surgical proce-
dures as assessed by prospective, multi-center, risk-adjusted 
ACS-NSQIP data. Surg Endosc 2008;12:2554-63. 
21. CULNAN DM, COONEY RN, et al. Apolipoprotein A-IV, 
a putative satiety/antiatherogenic factor, rises after gastric by-
pass. Obesity 2009;17:46-52. 
22. MORINO M, TOPPINO M, FORESTIERI P, et al. Mor-
tality after bariatric surgery: analysis of 13,871 morbidly obese 
patients from a national registry. Ann Surg 2007;246:1002-7; 
discussion 1007-9.
23. MARSK R, FREEDMAN J, TYNELIUS P, et al. Antiobe-
sity surgery in Sweden from 1980 to 2005: a population-based 
study with a focus on mortality. Ann Surg 2008;248:777-81.
24. BUCHWALD H, ESTOK R, FAHRBACH K, et al. Trends 
in mortality in bariatric surgery: a systematic review and me-
ta-analysis. Surgery 2007;142:621-32; discussion 632-5.
25. GONZALEZ R, SARR MG, et al. Diagnosis and contem-
porary management of anastomotic leaks after gastric bypass 
for obesity. J Am Coll Surg 2007;204:47-55.
26. BALIESTA C, BERINDOAGUE R, CABRERA M, et al. 
Management of anastomotic leaks after laparoscopic Roux-
en-Y gastric bypass. Obes Surg 2008;18:623-30.
27. CARO L, SANCHEZ C, RODRIGUEZ P, et al. Endo-
scopic balloon dilation of anastomotic strictures occurring 
after laparoscopic gastric bypass for morbid obesity. Dig Dis 
2008;26:314-7.
28. PATEL RA, BROLIN RE, GANDHI A. Revisional opera-
tions for marginal ulcer after Roux-en-Y gastric bypass. Surg 
Obes Relat Dis 2009;5:317-22.
Sažetak
LAPAROSKOPSKA ŽELUčANA PREMOSNICA ROUX-EN-Y ZBOG PREKOMJERNE PRETILOSTI – 
PRIKAZ SLUčAJA
T. Grgić, D. Diklić, D. Grgić, M. Nikolić, T. Kuliš i M. Bekavac-Bešlin
Morbidna pretilost danas je jedan od vodećih problema širom svijeta. U Hrvatskoj se jedna od pet odraslih osoba 
smatra pretilom, uz indeks tjelesne mase (BMI) veći od 30 kg/m2, bez razlike među spolovima. Indikacije za barijatrijsku 
kirurgiju su BMI >40 kg/m2 uz druge istodobne bolesti. Barijatrijski zahvati dijele se na restriktivne, malapsorcijske i kom-
binirane. Želučana premosnica Roux-en-Y je kombinirani barijatrijski zahvat koji je već postao standardom u SAD, a sve 
više se primjenjuje i u Europi. Žena u dobi od 47 godina s BMI 48,2 kg/m2 (105,5 kg) primljena je na odjel radi liječenja. 
Svi njezini napori da smanji tjelesnu težinu konzervativnim metodama pokazali su se neuspješnima. Uz to je bolovala od 
netolerancije glukoze, gastritisa, kronične opstruktivne plućne bolesti, hipertenzije i depresije. Temeljem iskustva stečenog 
u barijatrijskoj kirurgiji (podvezivanje želuca, gastrektomija sa skretnicom, duodenalni prekidač) odlučili smo prvi put u 
našoj bolnici izvesti laparoskopsku želučanu premosnicu Roux-en-Y. Bolesnica je otpuštena iz bolnice petog dana poslije 
operacije uz BMI 40,56 kg/m2 (tjelesna težina 100 kg), uz gubitak prekomjerne težine od 12,5%. Mjesec dana nakon za-
hvata njezin BMI je bio 38,54 kg/m2, gubitak prekomjerne težine 23,92% (tjelesna težina 95 kg).  
Ključne riječi: Tjelesni indeks mase; Pretilost, morbidna; Želučana premosnica, Roux-en-Y – metode; Prikaz slučaja

